The prognosis for patients with respiratory syncytial virus (RSV) or parainfluenza virus type 3 (PIV3) respiratory tract infection post allogeneic haematopoietic progenitor cell transplant (HPCT) is ...
AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody-based ...
Earnings call Sanofi delivered a robust Q1 2026 with net sales up 13.6% to EUR 10.5 billion and business EPS up 14% YoY, driven by strong performance in Dupixent, new launches, and recent acquisitions ...
Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...
2 Department of Thoracic Medicine, Royal Free and University College Medical School, University College London, UK 3 Centre for Medical Microbiology, Royal Free and University College Medical School, ...
3 Centre for General Practice, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium 4 Laboratory of Medical Microbiology, Vaccine & Infectious Disease ...
Introduction Respiratory viruses causing lower respiratory tract infections (LRTIs) are a major cause of hospital admissions in children. Since the course of these infections is unpredictable with ...
Background There is conflicting research about the association between asthma and poor educational attainment that may be due to asthma definitions. Our study creates seven categories of current ...
Diagnosing pneumonia in patients hospitalized for respiratory failure can be challenging, particularly when the patients are children. Children frequently carry bacterial pathogens in the upper throat ...
Systemic corticosteroids (SCS) are commonly used for acute exacerbation of COPD (AECOPD), but their effect in patients with COPD-bronchiectasis overlap remains unclear. Whether admission blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results